|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo M and Yan W: Epigenetics of gastric
cancer. Methods Mol Biol. 1238:783–799. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Terry MB, Gaudet MM and Gammon MD: The
epidemiology of gastric cancer. Semin Radiat Oncol. 12:111–127.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hammond SM: MicroRNAs as oncogenes. Curr
Opin Genet Dev. 16:4–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, Function and Role in Cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin
X and Cheng Y: MicroRNA-655-3p functions as a tumor suppressor by
regulating ADAM10 and β-catenin pathway in Hepatocellular
Carcinoma. J Exp Clin Cancer Res. 35:892016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen XF and Liu Y: MicroRNA-744 inhibited
cervical cancer growth and progression through apoptosis induction
by regulating Bcl-2. Biomed Pharmacother. 81:379–387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sheng W, Chen Y, Gong Y, Dong T, Zhang B
and Gao W: miR-148a inhibits self-renewal of thyroid cancer stem
cells via repressing INO80 expression. Oncol Rep. 36:3387–3396.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L and Yu P: miR-300 promotes
proliferation and EMT-mediated colorectal cancer migration and
invasion by targeting p53. Oncol Rep. 36:3225–3232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan J, Zhang H, Qu Y, Deng T, Huang D,
Liu R, Zhang L, Bai M, Zhou L, Ying G, et al: Onco-miR-130 promotes
cell proliferation and migration by targeting TGFβR2 in gastric
cancer. Oncotarget. 7:44522–44533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farooqi AA, Rehman ZU and Muntane J:
Antisense therapeutics in oncology: Current status. Onco Targets
Ther. 7:2035–2042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qu Y, Zhang H, Duan J, Liu R, Deng T, Bai
M, Huang D, Li H, Ning T, Zhang L, et al: MiR-17-5p regulates cell
proliferation and migration by targeting transforming growth
factor-beta receptor 2 in gastric cancer. Oncotarget.
7:33286–33296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan M, Li X, Tong D, Han C, Zhao R, He Y
and Jin X: miR-136 suppresses tumor invasion and metastasis by
targeting RASAL2 in triple-negative breast cancer. Oncol Rep.
36:65–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Wu J, Guan H, Cai J, Fang L, Li J
and Li M: MiR-136 promotes apoptosis of glioma cells by targeting
AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen W, Yang Y, Chen B, Lu P, Zhan L, Yu
Q, Cao K and Li Q: MiR-136 targets E2F1 to reverse cisplatin
chemosensitivity in glioma cells. J Neurooncol. 120:43–53. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen S, Yue H, Li Y, Qin J, Li K, Liu Y
and Wang J: Upregulation of miR-136 in human non-small cell lung
cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
Tumour Biol. 35:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Cui J, Zhang CH, Yang DJ, Chen JH,
Zan WH, Li B, Li Z and He YL: High-expression of DJ-1 and loss of
PTEN associated with tumor metastasis and correlated with poor
prognosis of gastric carcinoma. Int J Med Sci. 10:1689–1697. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng T, Meng X, Wang J, Chen X, Yin D,
Liang Y, Song X, Pan S, Jiang H and Liu L: PTEN- and p53-mediated
apoptosis and cell cycle arrest by FTY720 in gastric cancer cells
and nude mice. J Cell Biochem. 111:218–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He RF, Hu ZL and Wen JF: Biological
implication of PTEN gene expression in human gastric cancer and
related molecular mechanisms. Zhonghua Bing Li Xue Za Zhi.
36:324–328. 2007.(In Chinese). PubMed/NCBI
|
|
28
|
Sachdeva M and Mo YY: miR-145-mediated
suppression of cell growth, invasion and metastasis. Am J Transl
Res. 2:170–180. 2010.PubMed/NCBI
|
|
29
|
Wu D, Niu X, Pan H, Zhou Y, Zhang Z, Qu P
and Zhou J: Tumor-suppressing effects of microRNA-429 in human
renal cell carcinoma via the downregulation of Sp1. Oncol Lett.
12:2906–2911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Christgen M, Länger F and Kreipe H:
Histological grading of breast cancer. Pathologe. 37:328–336.
2016.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao H, Liu S, Wang G, Wu X, Ding Y, Guo
G, Jiang J and Cui S: Expression of miR-136 is associated with the
primary cisplatin resistance of human epithelial ovarian cancer.
Oncol Rep. 33:591–598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Loures LF, Candido EB, Vidigal PV, Seabra
MA, Marco LA and Silva-Filho AL: PTEN expression in patients with
carcinoma of the cervix and its association with p53, Ki-67 and
CD31. Rev Bras Ginecol Obstet. 36:205–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Araujo WM, Robbs BK, Bastos LG, de
Souza WF, Vidal FC, Viola JP and Morgado-Diaz JA: PTEN
overexpression cooperates with lithium to reduce the malignancy and
to increase cell death by apoptosis via PI3K/Akt suppression in
colorectal cancer cells. J Cell Biochem. 117:458–469. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou YH, Tan F, Hess KR and Yung WK: The
expression of PAX6, PTEN, vascular endothelial growth factor, and
epidermal growth factor receptor in gliomas: Relationship to tumor
grade and survival. Clin Cancer Res. 9:3369–3375. 2003.PubMed/NCBI
|
|
36
|
Koksal IT, Yasar D, Dirice E, Usta MF,
Karauzum S, Luleci G, Baykara M and Sanlioglu S: Differential PTEN
protein expression profiles in superficial versus invasive bladder
cancers. Urol Int. 75:102–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mithal P, Allott E, Gerber L, Reid J,
Welbourn W, Tikishvili E, Park J, Younus A, Sangale Z, Lanchbury
JS, et al: PTEN loss in biopsy tissue predicts poor clinical
outcomes in prostate cancer. Int J Urol. 21:1209–1214. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stambolic V, Suzuki A, de la Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mukhopadhyay UK, Mooney P, Jia L, Eves R,
Raptis L and Mak AS: Doubles game: Src-Stat3 versus p53-PTEN in
cellular migration and invasion. Mol Cell Biol. 30:4980–4995. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Waite KA and Eng C: Protean PTEN: Form and
function. Am J Hum Genet. 70:829–844. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nogueira C, Kim KH, Sung H, Paraiso KH,
Dannenberg JH, Bosenberg M, Chin L and Kim M: Cooperative
interactions of PTEN deficiency and RAS activation in melanoma
metastasis. Oncogene. 29:6222–6232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee H, Choi SK and Ro JY: Overexpression
of DJ-1 and HSP90alpha, and loss of PTEN associated with invasive
urothelial carcinoma of urinary bladder: Possible prognostic
markers. Oncol Lett. 3:507–512. 2012.PubMed/NCBI
|
|
43
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Tsuneyama K and Takano Y: Low expression of FHIT and PTEN
correlates with malignancy of gastric carcinomas: Tissue-array
findings. Appl Immunohistochem Mol Morphol. 15:432–440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ahn HS, Kim SH, Kodera Y and Yang HK:
Gastric cancer staging with radiologic imaging modalities and UICC
staging system. Dig Surg. 30:142–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
